A Pair of “ACEs” - E.V. Hersh, M. Wolff, P.A. Moore, K.N. Theken, H. Daniell, 2022
ACE2 as a potential therapeutic target for pandemic COVID-19 - RSC Advances (RSC Publishing) DOI:10.1039/D0RA08228G
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies | Internal and Emergency Medicine
SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications - ScienceDirect
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target | Intensive Care Medicine
Men's blood contains greater concentrations o | EurekAlert!
SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy - eBioMedicine
Frontiers | ACE2, Much More Than Just a Receptor for SARS-COV-2
IJMS | Free Full-Text | Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms
Should ACE-inhibitors and ARBs be stopped with COVID-19? — NephJC
Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic | Aging
SARS-CoV-2 receptor |Human ACE2-Fc | InvivoGen
ACE inhibitors, angiotensin receptor blockers and endothelial injury in COVID‐19 - Tetlow - 2021 - Journal of Internal Medicine - Wiley Online Library
COVID-19, ACE -inhibitors and angiotensin receptor blockers: The need to differentiate between early infection and acute lung injury
What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain
Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients | eLife
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
ACE inhibition, ACE2 and angiotensin-(1⿿7) axis in kidney and cardiac inflammation and fibrosis - ScienceDirect
IJMS | Free Full-Text | ACE2 and Innate Immunity in the Regulation of SARS-CoV-2-Induced Acute Lung Injury: A Review
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
COVID-19 and the Renin-Angiotensin System - Kidney International Reports
Molecules | Free Full-Text | Is It Still Relevant to Discover New ACE Inhibitors from Natural Products? YES, but Only with Comprehensive Approaches to Address the Patients’ Real Problems: Chronic Dry Cough
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 | Signal Transduction and Targeted Therapy
Frontiers | Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
